Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189

1.

Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?

Beavis AL, Yen TT, Stone RL, Wethington SL, Carr C, Son J, Chambers L, Michener CM, Ricci S, Burkett WC, Richardson DL, Staley AS, Ahn S, Gehrig PA, Torres D, Dowdy SC, Sullivan MW, Modesitt SC, Watson C, Veade A, Ehrisman J, Havrilesky L, Secord AA, Loreen A, Griffin K, Jackson A, Viswanathan AN, Jager LR, Fader AN.

Gynecol Oncol. 2020 Jan 13. pii: S0090-8258(19)31849-9. doi: 10.1016/j.ygyno.2019.12.028. [Epub ahead of print]

PMID:
31948730
2.

In Reply.

Dowdy SC, Kalogera E, Scott M.

Obstet Gynecol. 2020 Jan;135(1):219-220. doi: 10.1097/AOG.0000000000003639. No abstract available.

PMID:
31856109
3.

Using evidence to direct quality improvement efforts: Defining the highest impact complications after complex cytoreductive surgery for ovarian cancer.

Narasimhulu DM, Bews KA, Hanson KT, Chang YH, Dowdy SC, Cliby WA.

Gynecol Oncol. 2019 Nov 27. pii: S0090-8258(19)31628-2. doi: 10.1016/j.ygyno.2019.11.007. [Epub ahead of print]

PMID:
31785863
4.

Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy.

Leitao MM Jr, Zhou QC, Gomez-Hidalgo NR, Iasonos A, Baser R, Mezzancello M, Chang K, Ward J, Chi DS, Long Roche K, Sonoda Y, Brown CL, Mueller JJ, Gardner GJ, Jewell EL, Broach V, Zivanovic O, Dowdy SC, Mariani A, Abu-Rustum NR.

Gynecol Oncol. 2020 Jan;156(1):147-153. doi: 10.1016/j.ygyno.2019.11.003. Epub 2019 Nov 25.

PMID:
31780238
5.

Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma.

Schlappe BA, Weaver AL, McGree ME, Ducie J, Zahl Eriksson AG, Dowdy SC, Cliby WA, Glaser GE, Abu-Rustum NR, Mariani A, Leitao MM Jr.

Gynecol Oncol. 2020 Jan;156(1):62-69. doi: 10.1016/j.ygyno.2019.11.002. Epub 2019 Nov 24.

PMID:
31776037
6.

BRCA1 Deficiency Upregulates NNMT, Which Reprograms Metabolism and Sensitizes Ovarian Cancer Cells to Mitochondrial Metabolic Targeting Agents.

Kanakkanthara A, Kurmi K, Ekstrom TL, Hou X, Purfeerst ER, Heinzen EP, Correia C, Huntoon CJ, O'Brien D, Wahner Hendrickson AE, Dowdy SC, Li H, Oberg AL, Hitosugi T, Kaufmann SH, Weroha SJ, Karnitz LM.

Cancer Res. 2019 Dec 1;79(23):5920-5929. doi: 10.1158/0008-5472.CAN-19-1405. Epub 2019 Oct 16.

PMID:
31619387
7.

Dilution of Molecular-Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer.

Heitz F, Kommoss S, Tourani R, Grandelis A, Uppendahl L, Aliferis C, Burges A, Wang C, Canzler U, Wang J, Belau A, Prader S, Hanker L, Ma S, Ataseven B, Hilpert F, Schneider S, Sehouli J, Kimmig R, Kurzeder C, Schmalfeldt B, Braicu EI, Harter P, Dowdy SC, Winterhoff BJ, Pfisterer J, du Bois A.

Clin Cancer Res. 2020 Jan 1;26(1):213-219. doi: 10.1158/1078-0432.CCR-19-1741. Epub 2019 Sep 16.

PMID:
31527166
8.

Comparing risk stratification criteria for predicting lymphatic dissemination in endometrial cancer.

Kilts TP, Glaser GE, Langstraat CL, Kumar A, Weaver AL, Mc Gree ME, Gostout BS, Podratz KC, Dowdy SC, Cliby WA, Mariani A, Bakkum-Gamez JN.

Gynecol Oncol. 2019 Oct;155(1):21-26. doi: 10.1016/j.ygyno.2019.08.005. Epub 2019 Aug 10.

PMID:
31409487
9.

A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-alpha positive ovarian cancer.

Randall LM, Wenham RM, Low PS, Dowdy SC, Tanyi JL.

Gynecol Oncol. 2019 Oct;155(1):63-68. doi: 10.1016/j.ygyno.2019.07.010. Epub 2019 Jul 27.

PMID:
31362825
10.

Optimizing Preanesthesia Care for the Gynecologic Patient.

Dowdy SC, Kalogera E, Scott M.

Obstet Gynecol. 2019 Aug;134(2):395-408. doi: 10.1097/AOG.0000000000003323.

PMID:
31349358
11.

Improving the rate of surgical normothermia in gynecologic surgery.

Kumar A, Martin DP, Dhanorker SR, Brandt SR, Schroeder DR, Hanson AC, Cima RR, Dowdy SC.

Gynecol Oncol. 2019 Sep;154(3):590-594. doi: 10.1016/j.ygyno.2019.06.027. Epub 2019 Jul 5.

PMID:
31285083
12.

Evidence-based wound classification for vulvar surgery: Implications for risk adjustment.

Mert I, Cliby WA, Bews KA, Habermann EB, Dowdy SC.

Gynecol Oncol. 2019 Aug;154(2):280-282. doi: 10.1016/j.ygyno.2019.06.008. Epub 2019 Jun 25.

PMID:
31248667
13.

Enhanced Recovery After Surgery and Acute Postoperative Pain Management.

Kalogera E, Dowdy SC.

Clin Obstet Gynecol. 2019 Dec;62(4):656-665. doi: 10.1097/GRF.0000000000000475.

PMID:
31233423
14.

Enhanced recovery after surgery for ovarian cancer.

Dowdy SC.

Clin Adv Hematol Oncol. 2019 Apr;17(4):217-219. No abstract available.

PMID:
31188812
15.

International validation of Enhanced Recovery After Surgery Society guidelines on enhanced recovery for gynecologic surgery.

Wijk L, Udumyan R, Pache B, Altman AD, Williams LL, Elias KM, McGee J, Wells T, Gramlich L, Holcomb K, Achtari C, Ljungqvist O, Dowdy SC, Nelson G.

Am J Obstet Gynecol. 2019 Sep;221(3):237.e1-237.e11. doi: 10.1016/j.ajog.2019.04.028. Epub 2019 Apr 30.

16.

Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations-2019 update.

Nelson G, Bakkum-Gamez J, Kalogera E, Glaser G, Altman A, Meyer LA, Taylor JS, Iniesta M, Lasala J, Mena G, Scott M, Gillis C, Elias K, Wijk L, Huang J, Nygren J, Ljungqvist O, Ramirez PT, Dowdy SC.

Int J Gynecol Cancer. 2019 May;29(4):651-668. doi: 10.1136/ijgc-2019-000356. Epub 2019 Mar 15.

PMID:
30877144
17.

Developing a Clinico-Molecular Test for Individualized Treatment of Ovarian Cancer: The interplay of Precision Medicine Informatics with Clinical and Health Economics Dimensions.

Winterhoff B, Kommoss S, Heitz F, Konecny GE, Dowdy SC, Mullany SA, Park-Simon TW, Baumann K, Hilpert F, Brucker S, du Bois A, Schröder W, Burges A, Shen S, Wang J, Tourani R, Ma S, Pfisterer J, Aliferis CF.

AMIA Annu Symp Proc. 2018 Dec 5;2018:1093-1102. eCollection 2018.

18.

Cancer susceptibility gene mutations in type I and II endometrial cancer.

Long B, Lilyquist J, Weaver A, Hu C, Gnanaolivu R, Lee KY, Hart SN, Polley EC, Bakkum-Gamez JN, Couch FJ, Dowdy SC.

Gynecol Oncol. 2019 Jan;152(1):20-25. doi: 10.1016/j.ygyno.2018.10.019. Epub 2018 Oct 26.

19.

A pilot study of non-routine events in gynecological surgery: Type, impact, and effect.

Law KE, Hildebrand EA, Hawthorne HJ, Hallbeck MS, Branaghan RJ, Dowdy SC, Blocker RC.

Gynecol Oncol. 2019 Feb;152(2):298-303. doi: 10.1016/j.ygyno.2018.11.035. Epub 2018 Dec 6.

PMID:
30527338
20.

Beyond prophylaxis: Extended risk of venous thromboembolism following primary debulking surgery for ovarian cancer.

Wagner BE, Langstraat CL, McGree ME, Weaver AL, Sarangi S, Mokri B, Dowdy SC, Cliby WA, Kumar A, Bakkum-Gamez JN.

Gynecol Oncol. 2019 Feb;152(2):286-292. doi: 10.1016/j.ygyno.2018.11.021. Epub 2018 Nov 22.

PMID:
30471900
21.

Enhanced Recovery after Minimally Invasive Gynecologic Procedures with Bowel Surgery: A Systematic Review.

Kalogera E, Glaser GE, Kumar A, Dowdy SC, Langstraat CL.

J Minim Invasive Gynecol. 2019 Feb;26(2):288-298. doi: 10.1016/j.jmig.2018.10.016. Epub 2018 Oct 24.

PMID:
30366117
22.

Enhanced recovery after surgery in gynecologic oncology.

Glaser G, Dowdy SC, Peedicayil A.

Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:143-146. doi: 10.1002/ijgo.12622.

PMID:
30306585
23.

Quality indicators in gynecologic oncology.

Dowdy SC, Cliby WA, Famuyide AO.

Gynecol Oncol. 2018 Nov;151(2):366-373. doi: 10.1016/j.ygyno.2018.09.002. Epub 2018 Sep 13. Review. No abstract available.

PMID:
30220409
24.

Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy.

Schlappe BA, Weaver AL, Ducie JA, Eriksson AGZ, Dowdy SC, Cliby WA, Glaser GE, Soslow RA, Alektiar KM, Makker V, Abu-Rustum NR, Mariani A, Leitao MM Jr.

Gynecol Oncol. 2018 Nov;151(2):235-242. doi: 10.1016/j.ygyno.2018.08.022. Epub 2018 Aug 31.

25.

Identification of nine new susceptibility loci for endometrial cancer.

O'Mara TA, Glubb DM, Amant F, Annibali D, Ashton K, Attia J, Auer PL, Beckmann MW, Black A, Bolla MK, Brauch H, Brenner H, Brinton L, Buchanan DD, Burwinkel B, Chang-Claude J, Chanock SJ, Chen C, Chen MM, Cheng THT, Clarke CL, Clendenning M, Cook LS, Couch FJ, Cox A, Crous-Bous M, Czene K, Day F, Dennis J, Depreeuw J, Doherty JA, Dörk T, Dowdy SC, Dürst M, Ekici AB, Fasching PA, Fridley BL, Friedenreich CM, Fritschi L, Fung J, García-Closas M, Gaudet MM, Giles GG, Goode EL, Gorman M, Haiman CA, Hall P, Hankison SE, Healey CS, Hein A, Hillemanns P, Hodgson S, Hoivik EA, Holliday EG, Hopper JL, Hunter DJ, Jones A, Krakstad C, Kristensen VN, Lambrechts D, Marchand LL, Liang X, Lindblom A, Lissowska J, Long J, Lu L, Magliocco AM, Martin L, McEvoy M, Meindl A, Michailidou K, Milne RL, Mints M, Montgomery GW, Nassir R, Olsson H, Orlow I, Otton G, Palles C, Perry JRB, Peto J, Pooler L, Prescott J, Proietto T, Rebbeck TR, Risch HA, Rogers PAW, Rübner M, Runnebaum I, Sacerdote C, Sarto GE, Schumacher F, Scott RJ, Setiawan VW, Shah M, Sheng X, Shu XO, Southey MC, Swerdlow AJ, Tham E, Trovik J, Turman C, Tyrer JP, Vachon C, VanDen Berg D, Vanderstichele A, Wang Z, Webb PM, Wentzensen N, Werner HMJ, Winham SJ, Wolk A, Xia L, Xiang YB, Yang HP, Yu H, Zheng W, Pharoah PDP, Dunning AM, Kraft P, De Vivo I, Tomlinson I, Easton DF, Spurdle AB, Thompson DJ.

Nat Commun. 2018 Aug 9;9(1):3166. doi: 10.1038/s41467-018-05427-7.

26.

Surgical technical evidence review for gynecologic surgery conducted for the Agency for Healthcare Research and Quality Safety Program for Improving Surgical Care and Recovery.

Kalogera E, Nelson G, Liu J, Hu QL, Ko CY, Wick E, Dowdy SC.

Am J Obstet Gynecol. 2018 Dec;219(6):563.e1-563.e19. doi: 10.1016/j.ajog.2018.07.014. Epub 2018 Jul 19.

PMID:
30031749
27.

Results of a Prospective, Multicenter Initiative Aimed at Developing Opioid-prescribing Guidelines After Surgery.

Thiels CA, Ubl DS, Yost KJ, Dowdy SC, Mabry TM, Gazelka HM, Cima RR, Habermann EB.

Ann Surg. 2018 Sep;268(3):457-468. doi: 10.1097/SLA.0000000000002919.

PMID:
30004924
28.

Optimizing Blood Transfusion Practices Through Bundled Intervention Implementation in Patients With Gynecologic Cancer Undergoing Laparotomy.

Wallace SK, Halverson JW, Jankowski CJ, DeJong SR, Weaver AL, Weinhold MR, Borah BJ, Moriarty JP, Cliby WA, Kor DJ, Higgins AA, Otto HA, Dowdy SC, Bakkum-Gamez JN.

Obstet Gynecol. 2018 May;131(5):891-898. doi: 10.1097/AOG.0000000000002463.

29.

Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses.

Painter JN, O'Mara TA, Morris AP, Cheng THT, Gorman M, Martin L, Hodson S, Jones A, Martin NG, Gordon S, Henders AK, Attia J, McEvoy M, Holliday EG, Scott RJ, Webb PM, Fasching PA, Beckmann MW, Ekici AB, Hein A, Rübner M, Hall P, Czene K, Dörk T, Dürst M, Hillemanns P, Runnebaum I, Lambrechts D, Amant F, Annibali D, Depreeuw J, Vanderstichele A, Goode EL, Cunningham JM, Dowdy SC, Winham SJ, Trovik J, Hoivik E, Werner HMJ, Krakstad C, Ashton K, Otton G, Proietto T, Tham E, Mints M, Ahmed S, Healey CS, Shah M, Pharoah PDP, Dunning AM, Dennis J, Bolla MK, Michailidou K, Wang Q, Tyrer JP, Hopper JL, Peto J, Swerdlow AJ, Burwinkel B, Brenner H, Meindl A, Brauch H, Lindblom A, Chang-Claude J, Couch FJ, Giles GG, Kristensen VN, Cox A, Zondervan KT, Nyholt DR, MacGregor S, Montgomery GW, Tomlinson I, Easton DF, Thompson DJ, Spurdle AB.

Cancer Med. 2018 May;7(5):1978-1987. doi: 10.1002/cam4.1445. Epub 2018 Apr 2.

30.

Risk of Surgical Site Infection (SSI) following Colorectal Resection Is Higher in Patients With Disseminated Cancer: An NCCN Member Cohort Study.

Kamboj M, Childers T, Sugalski J, Antonelli D, Bingener-Casey J, Cannon J, Cluff K, Davis KA, Dellinger EP, Dowdy SC, Duncan K, Fedderson J, Glasgow R, Hall B, Hirsch M, Hutter M, Kimbro L, Kuvshinoff B, Makary M, Morris M, Nehring S, Ramamoorthy S, Scott R, Sovel M, Strong V, Webster A, Wick E, Aguilar JG, Carlson R, Sepkowitz K.

Infect Control Hosp Epidemiol. 2018 May;39(5):555-562. doi: 10.1017/ice.2018.40. Epub 2018 Mar 19.

31.

Uterine serous carcinoma: Reassessing effectiveness of platinum-based adjuvant therapy.

Tortorella L, Langstraat CL, Weaver AL, McGree ME, Bakkum-Gamez JN, Dowdy SC, Cliby WA, Keeney GL, Sherman ME, Weroha SJ, Mariani A, Podratz KC.

Gynecol Oncol. 2018 May;149(2):291-296. doi: 10.1016/j.ygyno.2018.02.022. Epub 2018 Mar 14.

PMID:
29550183
32.

Society of Gynecologic Oncology Future of Physician Payment Reform Task Force report: The Endometrial Cancer Alternative Payment Model (ECAP).

Ko EM, Havrilesky LJ, Alvarez RD, Zivanovic O, Boyd LR, Jewell EL, Timmins PF 3rd, Gibb RS, Jhingran A, Cohn DE, Dowdy SC, Powell MA, Chalas E, Huang Y, Rathbun J, Wright JD.

Gynecol Oncol. 2018 May;149(2):232-240. doi: 10.1016/j.ygyno.2018.02.010. Epub 2018 Mar 13.

PMID:
29544708
33.

Adjuvant therapy for women with high-risk endometrial carcinoma.

Dowdy SC, Glaser GE.

Lancet Oncol. 2018 Mar;19(3):268-269. doi: 10.1016/S1470-2045(18)30091-3. Epub 2018 Feb 12. No abstract available.

34.

Society of Gynecologic Oncology Clinical Outcomes Registry: From small beginnings come great things.

Dewdney SB, Dancisak AC, Lachance JA, Grendys EC Jr, Dowdy SC, Powell M, Schorge JO.

Gynecol Oncol. 2018 Mar;148(3):439-444. doi: 10.1016/j.ygyno.2018.01.021. Epub 2018 Feb 1.

PMID:
29395312
35.

Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) Centers.

Bergstrom J, Aloisi A, Armbruster S, Yen TT, Casarin J, Leitao MM Jr, Tanner EJ, Matsuno R, Machado KK, Dowdy SC, Soliman PT, Wethington SL, Stone RL, Levinson KL, Fader AN.

Gynecol Oncol. 2018 Mar;148(3):480-484. doi: 10.1016/j.ygyno.2018.01.002. Epub 2018 Jan 12.

36.

Adoption of Minimally Invasive Surgery and Decrease in Surgical Morbidity for Endometrial Cancer Treatment in the United States.

Casarin J, Multinu F, Ubl DS, Dowdy SC, Cliby WA, Glaser GE, Butler KA, Ghezzi F, Habermann EB, Mariani A.

Obstet Gynecol. 2018 Feb;131(2):304-311. doi: 10.1097/AOG.0000000000002428.

PMID:
29324598
37.

Impact of surgical approach and patient factors on Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey scoring in gynecologic surgery.

Wallace S, Hanson KT, Dowdy SC, Habermann EB.

Gynecol Oncol. 2018 Jan;148(1):28-35. doi: 10.1016/j.ygyno.2017.11.015. Epub 2017 Dec 6.

PMID:
29221835
38.

Geographic disparities in the distribution of the U.S. gynecologic oncology workforce: A Society of Gynecologic Oncology study.

Ricci S, Tergas AI, Long Roche K, Fairbairn MG, Levinson KL, Dowdy SC, Bristow RE, Lopez M, Slaughter K, Moore K, Fader AN.

Gynecol Oncol Rep. 2017 Nov 15;22:100-104. doi: 10.1016/j.gore.2017.11.006. eCollection 2017 Nov.

39.

Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease.

Ducie JA, Eriksson AGZ, Ali N, McGree ME, Weaver AL, Bogani G, Cliby WA, Dowdy SC, Bakkum-Gamez JN, Soslow RA, Keeney GL, Abu-Rustum NR, Mariani A, Leitao MM Jr.

Gynecol Oncol. 2017 Dec;147(3):541-548. doi: 10.1016/j.ygyno.2017.09.030. Epub 2017 Sep 29.

PMID:
28965698
40.

Enhanced recovery after surgery (ERAS®) in gynecologic oncology - Practical considerations for program development.

Nelson G, Dowdy SC, Lasala J, Mena G, Bakkum-Gamez J, Meyer LA, Iniesta MD, Ramirez PT.

Gynecol Oncol. 2017 Dec;147(3):617-620. doi: 10.1016/j.ygyno.2017.09.023. Epub 2017 Sep 23. No abstract available.

41.

In Reply.

Dowdy SC, Lovely JK, Bakkum-Gamez JN.

Obstet Gynecol. 2017 Oct;130(4):914-915. doi: 10.1097/AOG.0000000000002304. No abstract available.

PMID:
28937562
42.

Reducing infection rates through perioperative glycemic control - how sweet it is.

Dowdy SC, Curry TB, Cima RR.

Gynecol Oncol. 2017 Aug;146(2):215-216. doi: 10.1016/j.ygyno.2017.07.004. No abstract available.

PMID:
28716378
43.

Clinical Utility of Preoperative Computed Tomography in Patients With Endometrial Cancer.

Bogani G, Gostout BS, Dowdy SC, Multinu F, Casarin J, Cliby WA, Frigerio L, Kim B, Weaver AL, Glaser GE, Mariani A.

Int J Gynecol Cancer. 2017 Oct;27(8):1685-1693. doi: 10.1097/IGC.0000000000001076.

PMID:
28704325
44.

Enhanced recovery in gynecologic oncology - A sea change in perioperative management.

Dowdy SC, Nelson G.

Gynecol Oncol. 2017 Aug;146(2):225-227. doi: 10.1016/j.ygyno.2017.06.015. Epub 2017 Jun 20. No abstract available.

PMID:
28645426
45.

Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study.

Minig L, Heitz F, Cibula D, Bakkum-Gamez JN, Germanova A, Dowdy SC, Kalogera E, Zapardiel I, Lindemann K, Harter P, Scambia G, Petrillo M, Zorrero C, Zanagnolo V, Rebollo JMC, du Bois A, Fotopoulou C.

Ann Surg Oncol. 2017 Sep;24(9):2720-2726. doi: 10.1245/s10434-017-5919-y. Epub 2017 Jun 12.

PMID:
28608122
46.

Quinacrine in endometrial cancer: Repurposing an old antimalarial drug.

Kalogera E, Roy D, Khurana A, Mondal S, Weaver AL, He X, Dowdy SC, Shridhar V.

Gynecol Oncol. 2017 Jul;146(1):187-195. doi: 10.1016/j.ygyno.2017.04.022. Epub 2017 May 22.

PMID:
28545688
47.

Enhanced Recovery Program and Length of Stay After Laparotomy on a Gynecologic Oncology Service: A Randomized Controlled Trial.

Nelson G, Ramirez PT, Ljungqvist O, Dowdy SC.

Obstet Gynecol. 2017 Jun;129(6):1139. doi: 10.1097/AOG.0000000000002083. No abstract available.

PMID:
28538481
48.

Venous Thromboembolism: An Unrecognized Crisis in Gynecologic Oncology.

Bakkum-Gamez JN, Dowdy SC.

Obstet Gynecol. 2017 Jun;129(6):971-973. doi: 10.1097/AOG.0000000000002073. No abstract available.

PMID:
28486378
49.

Vaginal vs. robotic hysterectomy for patients with endometrial cancer: A comparison of outcomes and cost of care.

Nitschmann CC, Multinu F, Bakkum-Gamez JN, Langstraat CL, Occhino JA, Weaver AL, Cliby WA, Mariani A, Dowdy SC.

Gynecol Oncol. 2017 Jun;145(3):555-561. doi: 10.1016/j.ygyno.2017.03.002. Epub 2017 Apr 6.

PMID:
28392125
50.

Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes.

Kommoss S, Winterhoff B, Oberg AL, Konecny GE, Wang C, Riska SM, Fan JB, Maurer MJ, April C, Shridhar V, Kommoss F, du Bois A, Hilpert F, Mahner S, Baumann K, Schroeder W, Burges A, Canzler U, Chien J, Embleton AC, Parmar M, Kaplan R, Perren T, Hartmann LC, Goode EL, Dowdy SC, Pfisterer J.

Clin Cancer Res. 2017 Jul 15;23(14):3794-3801. doi: 10.1158/1078-0432.CCR-16-2196. Epub 2017 Feb 3.

Supplemental Content

Loading ...
Support Center